New

Smart Pills Market

2021

Smart Pills Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring); Disease Indication (Gastrointestinal Diseases, Neurological Disorders, Cancer, Inherited Disorders, Other Disease Indications); End User (Hospitals and Clinics, Research Institutes, Home Healthcare), and Geography

| Report Code: TIPHE100001238 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Market Insights

Smart Pills Market 2028 By Application, Disease Indication, End User, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



There is a tremendous increase in the use of smart pills in healthcare with a wide range of applications such as capsule endoscopy, patient monitoring, and drug delivery. Also known as smart medicines, smart pills are ingestible capsules embedded with miniaturized microelectronics. These pills primarily monitor the compliance of a patient to a prescribed drug regimen. Therefore, patient monitoring has become one of the major areas of application in this market. Smart pills are also used for various disease indications such as gastrointestinal diseases, cancer and neurological disorders.

MARKET SCOPE



The "Global Smart Pills Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the smart pills market with detailed market segmentation by application, disease indication, end user, and geography. The report provides key statistics on the market status of the leading smart pills market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on application, the market is bifurcated into capsule endoscopy, drug delivery, and patient monitoring
  • Based on disease indication, the market is bifurcated into gastrointestinal diseases, neurological disorders, cancer, inherited disorders, and other disease indications
  • Based on end user, the market is bifurcated into hospitals and clinics, research institutes, and home healthcare

MARKET DYNAMICS


Drivers



  • Increasing demand for advanced drug delivery system
  • Growing minimally invasive surgical procedures
  • Increasing awareness and support by the healthcare providers to use smart pills

Restraints



  • High cost of smart pills and lack of reimbursement in the developing regions is expected to slow down the growth of market.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The smart pills market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the smart pills market in these regions.

IMPACT OF COVID-19 ON SMART PILLS MARKET


COVID-19 pandemic has served vital growth opportunities for the smart pills market due to growing research and development activities. Furthermore, the growing demand for better healthcare facilities services has increased tremendously amid the COVID-19 pandemic. Therefore, it is expected to increase the use of smart pills in the coming years. In addition, the increasing demand for a proper diagnosis for COVID-19 infection is likely to enhance the growth of smart pills in the coming future.

MARKET PLAYERS



The report covers key developments in the smart pills market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from smart pills market are anticipated to lucrative growth opportunities in the future with the rising demand for smart pills in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Smart pills market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • CapsoVision, Inc.
  • Given Imaging, Inc.
  • Boston Scientific Corporation
  • Proteus Digital Health
  • Medtronic
  • Fujifilm Holdings Corporation
  • PENTAX Medical
  • Lucid Group Limited
  • SYNECTICS MEDICAL LTD
  • Gelesis.


The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Smart Pills Market - By Application
1.3.2 Smart Pills Market - By Disease Indication
1.3.3 Smart Pills Market - By End User
1.3.4 Smart Pills Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SMART PILLS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SMART PILLS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SMART PILLS MARKET - GLOBAL MARKET ANALYSIS
6.1. SMART PILLS - GLOBAL MARKET OVERVIEW
6.2. SMART PILLS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. SMART PILLS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. CAPSULE ENDOSCOPY
7.3.1. Overview
7.3.2. Capsule Endoscopy Market Forecast and Analysis
7.3.3. Small Bowel Video Capsule Endoscopy Market
7.3.3.1. Overview
7.3.3.2. Small Bowel Video Capsule Endoscopy Market Forecast and Analysis
7.3.4. Colon Capsule Endoscopy Market
7.3.4.1. Overview
7.3.4.2. Colon Capsule Endoscopy Market Forecast and Analysis
7.3.5. Controllable Capsule Endoscopy Market
7.3.5.1. Overview
7.3.5.2. Controllable Capsule Endoscopy Market Forecast and Analysis
7.3.6. Storable Capsule Endoscope Market
7.3.6.1. Overview
7.3.6.2. Storable Capsule Endoscope Market Forecast and Analysis
7.3.7. Other Capsule Endoscopy Market
7.3.7.1. Overview
7.3.7.2. Other Capsule Endoscopy Market Forecast and Analysis
7.4. DRUG DELIVERY
7.4.1. Overview
7.4.2. Drug Delivery Market Forecast and Analysis
7.5. PATIENT MONITORING
7.5.1. Overview
7.5.2. Patient Monitoring Market Forecast and Analysis
8. SMART PILLS MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE INDICATION
8.1. OVERVIEW
8.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
8.3. GASTROINTESTINAL DISEASES
8.3.1. Overview
8.3.2. Gastrointestinal Diseases Market Forecast and Analysis
8.4. NEUROLOGICAL DISORDERS
8.4.1. Overview
8.4.2. Neurological Disorders Market Forecast and Analysis
8.5. CANCER
8.5.1. Overview
8.5.2. Cancer Market Forecast and Analysis
8.6. INHERITED DISORDERS
8.6.1. Overview
8.6.2. Inherited Disorders Market Forecast and Analysis
8.7. OTHER DISEASE INDICATIONS
8.7.1. Overview
8.7.2. Other Disease Indications Market Forecast and Analysis
9. SMART PILLS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS AND CLINICS
9.3.1. Overview
9.3.2. Hospitals and Clinics Market Forecast and Analysis
9.4. RESEARCH INSTITUTES
9.4.1. Overview
9.4.2. Research Institutes Market Forecast and Analysis
9.5. HOME HEALTHCARE
9.5.1. Overview
9.5.2. Home Healthcare Market Forecast and Analysis
10. SMART PILLS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Smart Pills Market Overview
10.1.2 North America Smart Pills Market Forecasts and Analysis
10.1.3 North America Smart Pills Market Forecasts and Analysis - By Application
10.1.4 North America Smart Pills Market Forecasts and Analysis - By Disease Indication
10.1.5 North America Smart Pills Market Forecasts and Analysis - By End User
10.1.6 North America Smart Pills Market Forecasts and Analysis - By Countries
10.1.6.1 United States Smart Pills Market
10.1.6.1.1 United States Smart Pills Market by Application
10.1.6.1.2 United States Smart Pills Market by Disease Indication
10.1.6.1.3 United States Smart Pills Market by End User
10.1.6.2 Canada Smart Pills Market
10.1.6.2.1 Canada Smart Pills Market by Application
10.1.6.2.2 Canada Smart Pills Market by Disease Indication
10.1.6.2.3 Canada Smart Pills Market by End User
10.1.6.3 Mexico Smart Pills Market
10.1.6.3.1 Mexico Smart Pills Market by Application
10.1.6.3.2 Mexico Smart Pills Market by Disease Indication
10.1.6.3.3 Mexico Smart Pills Market by End User
10.2. EUROPE
10.2.1 Europe Smart Pills Market Overview
10.2.2 Europe Smart Pills Market Forecasts and Analysis
10.2.3 Europe Smart Pills Market Forecasts and Analysis - By Application
10.2.4 Europe Smart Pills Market Forecasts and Analysis - By Disease Indication
10.2.5 Europe Smart Pills Market Forecasts and Analysis - By End User
10.2.6 Europe Smart Pills Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Smart Pills Market
10.2.6.1.1 Germany Smart Pills Market by Application
10.2.6.1.2 Germany Smart Pills Market by Disease Indication
10.2.6.1.3 Germany Smart Pills Market by End User
10.2.6.2 France Smart Pills Market
10.2.6.2.1 France Smart Pills Market by Application
10.2.6.2.2 France Smart Pills Market by Disease Indication
10.2.6.2.3 France Smart Pills Market by End User
10.2.6.3 Italy Smart Pills Market
10.2.6.3.1 Italy Smart Pills Market by Application
10.2.6.3.2 Italy Smart Pills Market by Disease Indication
10.2.6.3.3 Italy Smart Pills Market by End User
10.2.6.4 Spain Smart Pills Market
10.2.6.4.1 Spain Smart Pills Market by Application
10.2.6.4.2 Spain Smart Pills Market by Disease Indication
10.2.6.4.3 Spain Smart Pills Market by End User
10.2.6.5 United Kingdom Smart Pills Market
10.2.6.5.1 United Kingdom Smart Pills Market by Application
10.2.6.5.2 United Kingdom Smart Pills Market by Disease Indication
10.2.6.5.3 United Kingdom Smart Pills Market by End User
10.2.6.6 Rest of Europe Smart Pills Market
10.2.6.6.1 Rest of Europe Smart Pills Market by Application
10.2.6.6.2 Rest of Europe Smart Pills Market by Disease Indication
10.2.6.6.3 Rest of Europe Smart Pills Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Smart Pills Market Overview
10.3.2 Asia-Pacific Smart Pills Market Forecasts and Analysis
10.3.3 Asia-Pacific Smart Pills Market Forecasts and Analysis - By Application
10.3.4 Asia-Pacific Smart Pills Market Forecasts and Analysis - By Disease Indication
10.3.5 Asia-Pacific Smart Pills Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Smart Pills Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Smart Pills Market
10.3.6.1.1 Australia Smart Pills Market by Application
10.3.6.1.2 Australia Smart Pills Market by Disease Indication
10.3.6.1.3 Australia Smart Pills Market by End User
10.3.6.2 China Smart Pills Market
10.3.6.2.1 China Smart Pills Market by Application
10.3.6.2.2 China Smart Pills Market by Disease Indication
10.3.6.2.3 China Smart Pills Market by End User
10.3.6.3 India Smart Pills Market
10.3.6.3.1 India Smart Pills Market by Application
10.3.6.3.2 India Smart Pills Market by Disease Indication
10.3.6.3.3 India Smart Pills Market by End User
10.3.6.4 Japan Smart Pills Market
10.3.6.4.1 Japan Smart Pills Market by Application
10.3.6.4.2 Japan Smart Pills Market by Disease Indication
10.3.6.4.3 Japan Smart Pills Market by End User
10.3.6.5 South Korea Smart Pills Market
10.3.6.5.1 South Korea Smart Pills Market by Application
10.3.6.5.2 South Korea Smart Pills Market by Disease Indication
10.3.6.5.3 South Korea Smart Pills Market by End User
10.3.6.6 Rest of Asia-Pacific Smart Pills Market
10.3.6.6.1 Rest of Asia-Pacific Smart Pills Market by Application
10.3.6.6.2 Rest of Asia-Pacific Smart Pills Market by Disease Indication
10.3.6.6.3 Rest of Asia-Pacific Smart Pills Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Smart Pills Market Overview
10.4.2 Middle East and Africa Smart Pills Market Forecasts and Analysis
10.4.3 Middle East and Africa Smart Pills Market Forecasts and Analysis - By Application
10.4.4 Middle East and Africa Smart Pills Market Forecasts and Analysis - By Disease Indication
10.4.5 Middle East and Africa Smart Pills Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Smart Pills Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Smart Pills Market
10.4.6.1.1 South Africa Smart Pills Market by Application
10.4.6.1.2 South Africa Smart Pills Market by Disease Indication
10.4.6.1.3 South Africa Smart Pills Market by End User
10.4.6.2 Saudi Arabia Smart Pills Market
10.4.6.2.1 Saudi Arabia Smart Pills Market by Application
10.4.6.2.2 Saudi Arabia Smart Pills Market by Disease Indication
10.4.6.2.3 Saudi Arabia Smart Pills Market by End User
10.4.6.3 U.A.E Smart Pills Market
10.4.6.3.1 U.A.E Smart Pills Market by Application
10.4.6.3.2 U.A.E Smart Pills Market by Disease Indication
10.4.6.3.3 U.A.E Smart Pills Market by End User
10.4.6.4 Rest of Middle East and Africa Smart Pills Market
10.4.6.4.1 Rest of Middle East and Africa Smart Pills Market by Application
10.4.6.4.2 Rest of Middle East and Africa Smart Pills Market by Disease Indication
10.4.6.4.3 Rest of Middle East and Africa Smart Pills Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Smart Pills Market Overview
10.5.2 South and Central America Smart Pills Market Forecasts and Analysis
10.5.3 South and Central America Smart Pills Market Forecasts and Analysis - By Application
10.5.4 South and Central America Smart Pills Market Forecasts and Analysis - By Disease Indication
10.5.5 South and Central America Smart Pills Market Forecasts and Analysis - By End User
10.5.6 South and Central America Smart Pills Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Smart Pills Market
10.5.6.1.1 Brazil Smart Pills Market by Application
10.5.6.1.2 Brazil Smart Pills Market by Disease Indication
10.5.6.1.3 Brazil Smart Pills Market by End User
10.5.6.2 Argentina Smart Pills Market
10.5.6.2.1 Argentina Smart Pills Market by Application
10.5.6.2.2 Argentina Smart Pills Market by Disease Indication
10.5.6.2.3 Argentina Smart Pills Market by End User
10.5.6.3 Rest of South and Central America Smart Pills Market
10.5.6.3.1 Rest of South and Central America Smart Pills Market by Application
10.5.6.3.2 Rest of South and Central America Smart Pills Market by Disease Indication
10.5.6.3.3 Rest of South and Central America Smart Pills Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SMART PILLS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. SMART PILLS MARKET, KEY COMPANY PROFILES
13.1. CAPSOVISION, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. GIVEN IMAGING, INC (MEDTRONIC)
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BOSTON SCIENTIFIC CORPORATION
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. PROTEUS DIGITAL HEALTH, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. FUJIFILM CORPORATION (FUJIFILM HOLDINGS CORPORATION)
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. PENTAX MEDICAL
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. SYNECTICS MEDICAL LTD
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. OLYMPUS
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. CHECK-CAP
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. KONINKLIJKE PHILIPS N.V.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS


The List of Companies

1. CapsoVision, Inc.
2. Given Imaging, Inc.
3. Boston Scientific Corporation
4. Proteus Digital Health
5. Medtronic
6. Fujifilm Holdings Corporation
7. PENTAX Medical
8. Lucid Group Limited
9. SYNECTICS MEDICAL LTD
10. Gelesis.
11. Philips Respironics
12. BodyCap-Medical
13. IntroMedic Co., Ltd.
14. Olympus Corporation
15. Check-Cap Ltd.
TIPHE100001238
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.